Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review
Current Oncology - Canada
doi 10.3747/co.22.2566
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 18, 2015
Authors
Publisher
MultiMed Inc.